J Korean Neurol Assoc.  1999 Jan;17(1):26-31.

A Pilot Study on Total Plasma Homocysteine Level of Patients with Cerebral Infarction

Affiliations
  • 1Department of Neurology, Soonchunhyang University Hospital, Seoul, Korea.

Abstract

BACKGROUND: Hyperhomocysteinemia has been known to be associated with cerebrovascular disease. It is toxic to vascular endothelial cell and promotes arteriosclerotic detachment. There was no study of the homocysteine level in ischemic stroke patients in Korea except case report. Therefore we measured total plasma homocysteine level in ischemic stroke patients and evaluated association with other stroke risk factors.
METHODS
We measured total plasma homocysteine level in 44 patients with ischemic stroke and 16 age-matched normal controls, and analyzed its relationship to other stroke risk factors. Total plasma homocysteine level was determined by using a radioenzymatic method.
RESULTS
Total plasma homocysteine level was 12.12 5.11 micromol/L in patients and 9.40 1.93 micromol/L in controls. It was 13.03 5.78 micromol/L in lacunar infarction and 9.96 1.57 micromol/L in territory infarction. The total plasma homocysteine level of the patients with hypertension, DM, hyperlipidemia, heart disease, smoking, alcohol, previous stroke, carotid bruit was not different statistically from those without them.
CONCLUSIONS
Total plasma homocysteine level was significantly higher in the ischemic stroke patients than that of controls. Lacunar infarction showed significantly higher level of total plasma homocysteine compared to territory infarction.

Keyword

Homocysteine; Ischemic stroke; Risk factor

MeSH Terms

Cerebral Infarction*
Endothelial Cells
Heart Diseases
Homocysteine*
Humans
Hyperhomocysteinemia
Hyperlipidemias
Hypertension
Infarction
Korea
Pilot Projects*
Plasma*
Risk Factors
Smoke
Smoking
Stroke
Stroke, Lacunar
Homocysteine
Smoke
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr